01st week of 2015 patent applcation highlights part 53 |
Patent application number | Title | Published |
20150005208 | LUBRICATING OIL COMPOSITION FOR INTERNAL COMBUSTION ENGINE | 2015-01-01 |
20150005209 | GREASE COMPOSITION | 2015-01-01 |
20150005210 | LUBRICANT ADDITIVE BOOSTER SYSTEM | 2015-01-01 |
20150005211 | Branched Acids | 2015-01-01 |
20150005212 | ACETIC ACID-CAPPED ESTOLIDE BASE OILS AND METHODS OF MAKING THE SAME | 2015-01-01 |
20150005213 | NEW ALDEHYDE AS PERFUMING INGREDIENT | 2015-01-01 |
20150005214 | WOODY ODORANTS | 2015-01-01 |
20150005215 | ORGANIC CLEANING COMPOSITION | 2015-01-01 |
20150005216 | Corrosion resistance when using chelating agents in carbon steel-containing equipment | 2015-01-01 |
20150005217 | CLEANING COMPOSITION CONTAINING A POLYSACCHARIDE HYBRID POLYMER COMPOSITION AND METHODS OF IMPROVING DRAINAGE | 2015-01-01 |
20150005218 | CLEANING COMPOSITION CONTAINING A POLYSACCHARIDE GRAFT POLYMER COMPOSITON AND METHODS OF IMPROVING DRAINAGE | 2015-01-01 |
20150005219 | Use of phenol compounds as activator for metal surface corrosion | 2015-01-01 |
20150005220 | LIQUID DETERGENT WITH INCREASED CLEANING PERFORMANCE | 2015-01-01 |
20150005221 | Preserving Personal Care Compositions | 2015-01-01 |
20150005222 | NOVEL USE OF NONIONICS AS RHEOLOGY MODIFIERS IN LIQUID CLEANING SOLUTIONS | 2015-01-01 |
20150005223 | Personal Care Compositions and Articles | 2015-01-01 |
20150005224 | SOAP WITH DISPERSED ARTICLES PRODUCING LIGHT AND/OR SOUND | 2015-01-01 |
20150005225 | SURFACTANTS DERIVED FROM OLIGOGLYCEROLS | 2015-01-01 |
20150005226 | Antibodies That Inhibit TSLP Activity | 2015-01-01 |
20150005227 | METHOD OF TREATING AN ISCHEMIA-REPERFUSION INJURY-RELATED DISORDER BY ADMINISTERING GPCR LIGANDS | 2015-01-01 |
20150005228 | PEPTIDES AND USES THEREOF | 2015-01-01 |
20150005229 | Methods and Pharmaceutical Composition for the Treatment of a Feeding Disorder with Early-Onset in a Patient | 2015-01-01 |
20150005230 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY | 2015-01-01 |
20150005231 | HALOGEN-STABILIZED INSULIN | 2015-01-01 |
20150005232 | INDAZOLE DERIVATIVES | 2015-01-01 |
20150005233 | TREATMENT OF HYPOGLYCEMIA | 2015-01-01 |
20150005234 | SOFT TISSUE IMPLANT | 2015-01-01 |
20150005235 | Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin | 2015-01-01 |
20150005236 | USE OF BETA-NERVE GROWTH FACTOR FOR INDUCING OVULATION IN MAMMALS | 2015-01-01 |
20150005237 | PEPTIDIC INHIBITOR OF SIGNAL TRANSMISSION FROM G-ALPHA-S TO G-ALPHA-I-COUPLED RECEPTOR CASCADES | 2015-01-01 |
20150005238 | Treatment of coagulopathy with hyperfibrinolysis | 2015-01-01 |
20150005239 | Agonists of Neurotrophin Receptors and Their Use as Medicaments | 2015-01-01 |
20150005240 | THERAPEUTIC METHOD OF TREATMENT FOR INHIBITING TUMOR DEVELOPMENT USING TAMM-HORSFALL GLYCOPROTEIN (THP) AS IMMUNOSTIMULATING DRUG AND COMPOSITIONS | 2015-01-01 |
20150005241 | LINACLOTIDE COMPOSITIONS | 2015-01-01 |
20150005242 | AROMATIC-CATIONIC PEPTIDES AND USES OF SAME | 2015-01-01 |
20150005243 | NMR-BASED METABOLITE SCREENING PLATFORM | 2015-01-01 |
20150005244 | PHARMACEUTICAL FORMULATIONS | 2015-01-01 |
20150005245 | Sialic Acid Dimers | 2015-01-01 |
20150005246 | Use of Jasmonate to Treat Bladder Dysfunction | 2015-01-01 |
20150005247 | COMPOSITIONS CONTAINING AT LEAST TWO PHENOLIC COMPOUNDS, A LIPID-SOLUBLE ANTIOXIDANT AND AT LEAST ONE HYDROTROPE FOR COSMETIC USE | 2015-01-01 |
20150005248 | Compositions and Methods for Culturing Spirochetes | 2015-01-01 |
20150005249 | Readthrough Inducing Agent and Drug for Treating Genetic Disease Caused by Nonsense Mutation | 2015-01-01 |
20150005250 | TELOMERASE REVERSE TRANSCRIPTASE DEFICIENCY AS DIAGNOSTIC MARKER OF MYELODYSPLASTIC SYNDROME | 2015-01-01 |
20150005251 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | 2015-01-01 |
20150005252 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | 2015-01-01 |
20150005253 | NOVEL COMBINATIONS FOR TREATING ACUTE MYELOID LEUKAEMIA OR CHRONIC MYELOID LEUKAEMIA | 2015-01-01 |
20150005254 | METHODS FOR TREATING OCULAR INFLAMMATORY DISORDERS | 2015-01-01 |
20150005255 | COSMETIC COMPOSITION, FORMULATION IN GEL-CREAM AND ITS USE | 2015-01-01 |
20150005256 | Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes in Mammalian Systems via an Ecdysone Receptor Complex | 2015-01-01 |
20150005257 | ARYLALKYLOXY PYRIMIDINE DERIVATIVE, PESTICIDE FOR AGRICULTURAL AND HORTICULTURAL USE CONTAINING ARYLALKYLOXY PYRIMIDINE DERIVATIVE AS ACTIVE INGREDIENT, AND USE OF SAME | 2015-01-01 |
20150005258 | Modified Creatine Compounds | 2015-01-01 |
20150005259 | Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment | 2015-01-01 |
20150005260 | METHODS FOR THE DETECTION AND THE TREATMENT OF DIASTOLIC DYSFUNCTION | 2015-01-01 |
20150005261 | METHODS TO MODULATE RAC1 IMPORT AND TO TREAT PULMONARY FIBROSIS | 2015-01-01 |
20150005262 | HYPOXIA ACTIVATED PRODRUGS AND MTOR INHIBITORS FOR TREATING CANCER | 2015-01-01 |
20150005263 | ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS IN COMBINATION WITH CHK1 INHIBITORS FOR TREATING CANCER | 2015-01-01 |
20150005264 | PREDICTIVE BIOMARKER FOR HYPOXIA-ACTIVATED PRODRUG THERAPY | 2015-01-01 |
20150005265 | METHODS AND COMPOSITIONS FOR COMBINATION THERAPY USING P13K/MTOR INHIBITORES | 2015-01-01 |
20150005266 | TOPICAL COMPOSITIONS FOR TREATMENT OF SKIN CONDITIONS | 2015-01-01 |
20150005267 | ANXIOLYTIC MARCGRAVIACEAE COMPOSITIONS CONTAINING BETULINIC ACID, BETULINIC ACID DERIVATIVES, AND METHODS | 2015-01-01 |
20150005268 | METHODS AND COMPOSITIONS FOR TREATING CANCER | 2015-01-01 |
20150005269 | Treatment of Heart Failure and Sudden Cardiac Death | 2015-01-01 |
20150005270 | COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION | 2015-01-01 |
20150005271 | CONTROLLED RELEASE DELIVERY SYSTEM FOR NASAL APPLICATIONS AND METHOD OF TREATMENT | 2015-01-01 |
20150005272 | METHODS FOR REDUCING OR PREVENTING TRANSPLANT REJECTION IN THE EYE AND INTRAOCULAR IMPLANTS FOR USE THEREFOR | 2015-01-01 |
20150005273 | USE OF AVOCADO SKIN FOR OBTAINING AN AVOCADO UNSAPONIFIABLE MATERIAL ENRICHED WITH SATURATED ALIPHATIC HYDROCARBONS AND WITH STEROLS | 2015-01-01 |
20150005274 | USE OF SQUALAMINE OR ANALOGUE AS A DISINFECTING AGENT | 2015-01-01 |
20150005275 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS. | 2015-01-01 |
20150005276 | 1,2,4-TRIAZINE-4-AMINE DERIVATIVES | 2015-01-01 |
20150005277 | Protein Kinase Inhibitors and Uses Thereof | 2015-01-01 |
20150005278 | SULFOXIMINE SUBSTITUTED QUINAZOLINES FOR PHARMACEUTICAL COMPOSITIONS | 2015-01-01 |
20150005279 | PRIMARY CARBOXAMIDES AS BTK INHIBITORS | 2015-01-01 |
20150005280 | SUBSTITUTED HETEROCYCLIC COMPOUNDS AS TROPOMYOSIN RECEPTOR KINASE A (TRKA) INHIBITORS | 2015-01-01 |
20150005281 | PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS KINASE INHIBITORS | 2015-01-01 |
20150005282 | POLYCYCLIC DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF | 2015-01-01 |
20150005283 | ANTIVIRAL COMPOUNDS | 2015-01-01 |
20150005284 | Furo[3,2-b]- and thieno[3,2-b]pyridin derivatives | 2015-01-01 |
20150005285 | Nitrogen containing compounds | 2015-01-01 |
20150005286 | FLUORINATED ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | 2015-01-01 |
20150005287 | QUINOLONE COMPOUND | 2015-01-01 |
20150005288 | SUBSTITUTED PHENYLIMIDAZOPYRAZOLES AND USE THEREOF | 2015-01-01 |
20150005289 | COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY | 2015-01-01 |
20150005290 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING SALT SENSITIVITY OF BLOOD PRESSURE | 2015-01-01 |
20150005291 | Compositions for Increasing Hair Growth | 2015-01-01 |
20150005292 | METHOD AND COMPOSITION FOR TREATING ALZHEIMER-TYPE DEMENTIA | 2015-01-01 |
20150005293 | 5-Membered Heterocyclic Amides And Related Compounds | 2015-01-01 |
20150005294 | AZAHETEROCYCLIC COMPOUNDS | 2015-01-01 |
20150005295 | 4,4-DISUBSTITUTED-1,4-DIHYDROPYRIMIDINES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B | 2015-01-01 |
20150005296 | COMPOUNDS, COMPOSITIONS AND METHODS | 2015-01-01 |
20150005297 | 2,4-Pyrimidinediamine Compounds and Their Uses | 2015-01-01 |
20150005298 | ARYLPIPERAZINE DERIVATIVES AND METHODS OF UTILIZING SAME | 2015-01-01 |
20150005299 | PYRROLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY | 2015-01-01 |
20150005300 | PYRIDAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS | 2015-01-01 |
20150005301 | KINASE INHIBITOR POLYMORPHS | 2015-01-01 |
20150005302 | 1,5-NAPHTHYRIDINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME | 2015-01-01 |
20150005303 | 5-SUBSTITUTED ISOINDOLINE COMPOUNDS | 2015-01-01 |
20150005304 | Pyran-Spirocyclic Piperidine Amides as Modulators of Ion Channels | 2015-01-01 |
20150005305 | NOVEL MORPHOLINYL DERIVATIVES USEFUL AS MOGAT-2 INHIBITORS | 2015-01-01 |
20150005306 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT-RELATED DISEASE COMPRISING MORPHOLINE OR PIPERAZINE BASED COMPOUNDS, AND DONEPEZIL | 2015-01-01 |
20150005307 | Drug Delivery Technology | 2015-01-01 |